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KT2We investigated themechanisms of two tryptophan-rich antibacterial peptides (KT2 and RT2) obtained in a pre-
vious optimization screen for increased killing of both Gram-negative and Gram-positive bacteria pathogens. At
their minimal inhibitory concentrations (MICs), these peptides completely killed cells of multidrug-resistant,
enterohemorrhagic pathogen Escherichia coli O157:H7 within 1–5 min. In addition, both peptides exhibited
anti-bioﬁlm activity at sub-MIC levels. Indeed, these peptides prevented bioﬁlm formation and triggered killing
of cells inmature E. coliO157:H7 bioﬁlms at 1 μM. Both peptides bound to bacterial surface LPS as assessed using
the dansyl-polymyxin displacement assay, and were able to interact with the lipids of liposomes as determined
by observing a tryptophan blue shift. Interestingly, even though these peptides were highly antimicrobial, they
did not induce pore formation or aggregates in bacterial cell membranes. Instead these peptides readily penetrat-
ed into bacterial cells as determined by confocal microscopy of labeled peptides. DNA binding assays indicated
that both peptides bound to DNA with higher afﬁnity than the positive control peptide buforin II. We propose
that cationic peptides KT2 and RT2 bind to negatively-charged LPS to enable self-promoted uptake and, subse-
quently interact with cytoplasmic membrane phospholipids through their hydrophobic domains enabling trans-
location across the bacterial membrane and entry into cells within minutes and binding to DNA and other
cytoplasmic membrane. Due to their dual antimicrobial and anti-bioﬁlm activities, these peptides may ﬁnd use
as an alternative to (or in conjunctionwith) conventional antibiotics to treat acute infections caused by plankton-
ic bacteria and chronic, bioﬁlm-related infections.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Bacterial drug resistance is a major problem in human health as it
has led to the reduced efﬁcacy of conventional antibiotics. Thus, the
identiﬁcation of novel antibiotic compounds is essential. Antimicrobial
peptides have been proposed as a promising alternative to conventional
antibiotics in part due to their potency at low concentrations and to the
fact that they are less prone to select for antimicrobial resistance [1–4].
Certain peptide antibiotics that exhibit potent antimicrobial properties
have been designed and synthesized based on their biochemical and
biophysical properties. However, the relationship between these prop-
erties and antibacterial activity is unclear. Twomain types of antibacte-
rial mechanisms have been reported involving the bacterial membrane
as a target and diverse intracellular targets, and it has been further1 604 827 5566.
nt of Biochemistry, Faculty of
fax: +66 43 342911.
ck), somkly@kku.ac.thsuggested that peptides can have complex mechanisms involving mul-
tiple targets [1–4]. Membrane targeting has been proposed to involve
the loss of cellular integrity as a result of perforation of membranes
and diverse hypotheses have been used to explain this including the
barrel stave channel, torroidal pore, carpet and aggregate models
[1–3]. For example, the antibacterial mechanisms of magainin II [5],
alamethicin [6] and polymyxin B [7] have been reported to involve
torroidal pores, barrel stave channels and carpetmechanism respective-
ly. Many antibacterial peptides have been reported to translocate across
the cytoplasmic membrane to access intracellular targets [2,3], includ-
ing e.g. buforin II (binds to DNA) [8] and PR-39 (inhibits DNA/RNA/pro-
tein synthesis) [9].
Here we characterized the mechanism of action of two antimi-
crobial peptides KT2 (NGVQPKYKWWKWWKKWW-NH2) and RT2
(NGVQPKYRWWRWWRRWW-NH2) that differ only by 4 K → R
substitutions. These peptides were previously found to have good anti-
bacterial activity against Escherichia coli and Salmonella typhi but to be
non-toxic against human red blood cells, Vero kidney epithelial cells
from African green monkey and RAW 264.7 mouse macrophage cells
[10]. Both peptides are disordered in buffer but substantially α-helical
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and membrane mimetics, the work here suggested that they act intra-
cellularly rather than by damaging membranes.
2. Materials and methods
2.1. Chemical and reagents
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-
glycero-3-phospho-rac-(1-glycerol) (DOPG) and a miniextruder for
making liposomes from these lipids were obtained from Avanti Polar
Lipids, Inc. (Alabaster, AL, USA). 8-aminonaphthalene-1,3,6 trisulfonic
acid (ANTS)/p-xylene-bis-pyridinium bromide (DPX) and Vybrant Dil
cell-labeling solution were gained from Invitrogen (Oregon, USA).
Dansyl-polymyxin was synthesized by Evan F. Haney. LPS from
Escherichia coli 0111:B4 which was puriﬁed by phenol extraction was
purchased from Sigma-Aldrich (USA). EcoR1 digested DNA was obtain-
ed from Promega US G1721, Madison, WI, USA.
2.2. Peptide synthesis
Peptides and FITC (ﬂuorescein isothiocyanate) labeled peptides at N
terminal were synthesized by standard Fmoc solid phase chemistry at
GL Biochem (Shanghai, China) and puriﬁed to ≥95% purity using
(RP)-HPLC (stationary phase: C-18, mobile phase: varying from 5% to
20% acetonitrile in water, 0–20 min). The exact molecular weight of
each peptide was conﬁrmed via MALDI-TOF MS.
2.3. Killing kinetic
E. coli O157:H7 cells were inoculated in LB broth in mid-log phase
(OD600 = 0.5–0.6) and then the suspension was diluted in 1× BM2
salt to an OD600 equivalent of 0.001 (~1 × 106 CFU/ml). Subsequently
cells were treated with peptides at concentrations corresponding to
their MIC against E. coli. The percentage of bacterial survival was subse-
quently monitored at time points 0, 1, 5, 10, 60 min by assessing colony
forming units after plating on LB agar plates overnight [11]. Percent sur-
vival was calculated as (T60/T0) × 100, where T60 and T0 represented
the colony forming units at 60 min and at the time before adding the
peptides respectively.
2.4. Bioﬁlm ﬂow cell assays
E. coliO157:H7 bioﬁlmswere grown as previously described [12] for
72 h in BM2 minimal glucose medium [62 mM potassium phosphate
buffer, pH 7.0, 7 mM (NH4)2SO4, 2 mMMgSO4, 10 μM FeSO4, containing
0.4% (wt/vol) glucose as a carbon source] at 37 °C in ﬂow cell chambers
with channel dimensions of 1 × 4 × 40 mm in the absence or presence
of 1 μM KT2 and RT2 in the ﬂow-through medium. Bioﬁlm cells were
stained using the Live/Dead BacLight bacterial viability kit (Molecular
Probes, Eugene, OR) prior to confocal microscopy performed using a
confocal laser scanning microscope (Olympus, Fluoview FV1000).
Three-dimensional reconstructions of the resultant bioﬁlms were gen-
erated by using the Imaris software package (Bitplane AG).
2.5. LPS binding
Binding of peptides to E. coli 0111:B4 LPS was assessed using the
dansyl-polymyxin displacement assay as previously described [13].
The I50 was the concentration that decreased the maximal ﬂuorescence
of bound dansyl polymyxin by 50%.
2.6. Aggregation
The aggregation assay was performed as previously described [14].
Brieﬂy, large unilamellar vesicles (LUV/liposomes) were prepared bydissolving phospholipids (DOPG and DOPC at a weight ratio of 2:3) in
chloroform, and then evaporating overnight to obtain lipid ﬁlms. The
lipid ﬁlmswere then hydrated by the addition of 10mMTris–HCl buffer
and shaking to obtain multilamellar vesicles. After 5 freeze-thaw cycles
in CO2, the vesicles were extruded 20 times through a miniextruder
with a 0.2mmpolycarbonatemembrane tomake LUV. The ability of an-
tibacterial peptides to trigger LUV aggregationwas determined by using
a microplate reader to monitor the absorbance at 415 nm after incuba-
tion with peptides for 15 min at peptide to lipid molar ratios of
1:1–1:20. The absorbance of LUVs suspended in 20 mM Tris–HCl was
subtracted as the background from the absorbance of LUV in the pres-
ence of peptides.
2.7. Membrane leakage
LUVs were prepared as above except lipid ﬁlms were hydrated by
adding 10 mM Tris–HCl buffer, pH 7.4, which contains 12.5 mM ANTS
ﬂuorophore, 45 mM DPX quencher, 20 mM NaCl [15]. The free dye
and quencherwere removed from the resultant LUVs by using gel ﬁltra-
tion chromatography on Sephadex G 25. The liposome concentration
was tested by calorimetry [16]. Dynamic light scattering was used to
measure the liposome size which was 0.135 μm. The peptides were
added into the liposome suspension at a peptide to lipid molar ratio of
1:1 to 1:100. The peptides caused release of ANTS aswell as the quench-
er DPXwhichwhen diluted into the extra-liposome volume dissociated
leading to an increase in ANTS ﬂuorescence. Therefore, after incubation
for 60 min, the ANTS ﬂuorescence intensity was measured using a
SpectraMax M5 microplate reader (Molecular Devices) at an excitation
wavelength of 386 nm and emission wavelength of 512 nm. The
percentage of small molecular ANTS leakage was calculated as the
following formula (Fs− Fn)100/FP− Fn where Fs, Fn and FP represent
the ﬂuorescence intensity of the peptide-treated liposome suspension,
negative control (liposome suspension without peptide) and 2%
Triton × 100-treated liposomes (100% leakage control), respectively.
The Fs values were corrected by subtracting the background ﬂuores-
cence of peptide in buffer.
2.8. Interaction with membranes: tryptophan blue shift
The entry of tryptophan in a peptide into a hydrophobic environ-
ment such as a membrane, leads to an increase in ﬂuorescence and a
blue shift as the tryptophan head group has increasedmobility. A previ-
ously reported method [17] was adapted whereby the change in the
maximum emission spectrum of tryptophan amino acids of AMPs (An-
timicrobial peptides) upon interaction with LUVmimicking the bacteri-
al membrane was determined by using a Multifunction Microplate
Reader (Thermo Fisher, Finland). Liposomes and peptides were mixed
in 20 mM Tris–HCl at molar ratios ranging from 1:1 to 1:20. After exci-
tation at 280 nm, emission spectrawere recorded from300 to 400 nmat
a scan rate of 60 nm/min. The spectra of the liposome-only background
was subtracted from that of peptides in the presence of liposomes
(0.2 mM) and comparedwith the peak emission wavelength of peptide
alone in buffer at the same concentrations.
2.9. DNA binding assay
The binding of peptides to DNA was examined by a gel retardation
assay as described by Park et al. [8]. EcoRI-treated DNA was used and
mixed with 10× binding buffer comprised of 100 mM Tris–HCl,
200 mM KCl, 10 mM EDTA, 10 mM DTT and 50% (v/v) glycerol, water
and peptides at increasing peptide to DNA ratios of 0:1, 0.5:1, 1:1, 2:1,
4:1 and 8:1. Magainin II and buforin II were used as negative and posi-
tive controls respectively. After incubation for 1 h at 25 °C, 2 μl of loading
buffer was mixed and loaded on a 0.75% agarose/TAE gel and run at
108V and 70mA for 1.5 h afterwhich the gelwas stainedwith ethidium
bromide.
Fig. 1. Killing kinetics. (A) Time-kill study of E. coli O157:H7 exposed to different concen-
trations of peptide RT2. The experiment was performed three times. (B) Killing curve of E.
coliO157:H7 exposed to KT2 at various concentrations relative to theMIC. The experiment
was performed three times.
1354 T. Anunthawan et al. / Biochimica et Biophysica Acta 1848 (2015) 1352–13582.10. Translocation assays: bacterial cells
Bacterial cells were grown to mid-log phase and then diluted to a
ﬁnal OD600 of 0.001. The cells were washed 3 times with phosphate
buffered saline (PBS) and resuspended in PBS. Subsequently, the ﬂuo-
rescein isothiocyanate (FITC)-labeled peptides (at 0.5× and 2× MIC)
were incubated for 60 min after which the treated bacterial cells were
centrifuged at 5000 rpm for 15 min. The pellet was collected and
washed 3 times and then resuspended in PBS. The location of FITC-
labeled peptides was then visualized using confocal microscopy at an
excitation wavelength of 490 nm and an emission wavelength of
525 nm.
2.11. Translocation assays: GUVs
Giant unilamellar vesicles (GUVs) were prepared as outlined previ-
ously [18,19]. Brieﬂy, phospholipids (3DOPC: 2DOPG weight ratio)
were dissolved in chloroform, and 1 μl of Vybrant Dil then lipid ﬁlms
were obtained by evaporating the solvent under a stream of N2 and
then subjecting the ﬁlm to high vacuum for at least 2 h. The lipid ﬁlms
were pre hydrated with steam and then hydrated by gently adding
200 μl of 250 mM saccharose. After incubation for at least 60 min, a
GUV suspension of approximately 2.5 mM lipids was obtained. The
FITC-labeled peptides and Vybrant Dil dye labeled GUVsweremixed to-
gether at a 1:1 peptide to lipid molar ratio. The location of FITC-labeled
peptides was then detected by using confocal microscopy at an excita-
tion wavelength of 549 nm and an emission wavelength of 565 nm.
3. Results and discussion
3.1. Time kill assay
Most AMPs kill very rapidly. KT2 and RT2 were able to kill E. coli
O157:H7 at concentrations of 5 μM/11 μg/ml and 18 μM/46 μg/ml (the
MICs of KT2 and RT2 respectively, against E. coli within 1 min and
5min, respectively). Cell killing at lower concentrations clearly indicated
that the antibacterial mechanism of these peptides was concentration-
dependent (Fig. 1A and B). These results extended previous studies
using scanning electron microscopy in which perturbation of E. coli
ATCC 25922 was detected within 1 min of incubation at 10-fold higher
concentrations of peptides [10].
3.2. Anti-bioﬁlm activity
Flow cell methodology was used to assess the anti-bioﬁlm proper-
ties of peptides KT2 and RT2. E. coli O157:H7 bioﬁlms were grown for
3 days in ﬂow cell chambers and were left untreated or were treated
with 1 μM of each peptide (i.e. well below the planktonic MIC) starting
at either day 0 (inhibition conditions) or day 2 (eradication conditions)
(Fig. 2). When added to the ﬂow-through medium at the beginning of
bioﬁlm growth on day 0, both peptides completely prevented bioﬁlm
development at concentrations far below their MIC (Fig. 2, upper right
panels). Both peptides substantially induced killing of cells present in
pre-existing bioﬁlms (i.e. when peptides were ﬁrst added after 2 days
of bioﬁlm growth) (Fig. 2, bottom panels).
3.3. LPS binding
The initial interaction of cationic peptideswithGramnegative bacte-
ria involves self promoted uptake across the outer membrane whereby
the peptides bind to anionic LPS on the surface and cause perturbation
of outer membrane structure to promote their own passage across the
membrane [13]. Since both peptides RT2 and KT2 showed antibacterial
activity against E. coli and characteristic cell blebbing in scanning elec-
tron micrographs [10], we tested here their ability to bind to LPS, a
major membrane component of Gram-negative bacteria using theDPX displacement assay. Peptides KT2 and RT2 were able to displace
dansyl-polymyxin effectively with I50 of 4.6 and 5.8 μM respectively
whereas polymyxin B, which was used as a positive control [20] had
an I50 of 0.76 μM (Fig. 3). These data are consistent with both peptides
being able to initially interact with the outer membrane at divalent cat-
ion binding sites on LPS, indicating transposition across the outer mem-
brane by self-promoted uptake [11,13].
3.4. Aggregation of lipids
Lipid aggregation has been proposed to be involved in the killing
bacteria by certain AMPs, consistent with the carpet [15], torroidal
pore [5], and aggregate [13] models. Polymyxin B and magainin II
were used as positive controls as their mechanisms of action have
been proposed to involve membrane disruption [4,5]. Polymyxin B ex-
hibited a strong ability to induce liposome aggregation (Fig. 4) while
magainin II was quite weak (Fig. 4). In contrast, buforin II, which acts
through an intracellular target [8], as well as RT2 and KT2, were unable
to trigger liposome aggregation even at lipid peptide molar ratios of 1:1
(Fig. 4).
3.5. Membrane leakage
The ability of peptides to cause perforation of liposomes as assessed
by leakage of small molecules has been used to determine whether
peptides can disrupt membranes. Most cationic peptides will do this
at effective peptide to lipid ratios, but many only cause liposome perfo-
ration at high peptide to lipid ratios. Magainin II was able tomake pores
on bacterial-membrane mimicking liposomes resulting in the mem-
brane leakage of almost 100% at peptide-to-lipid molar ratios of 1:5
and 1:10 as shown previously [5]. Buforin II showed a substantially de-
creased ability to induce pore formation in liposomes [21], when
Fig. 2. Peptides KT2 and RT2 prevented bioﬁlm formation and killed cells within pre-formed E. coli O157 bioﬁlms. Sub-lethal concentrations (1 μM) of peptides KT2 and RT2 were used.
Inhibition of bioﬁlm development was tested by adding peptide at day 0 into the ﬂow-through medium of the ﬂow cell apparatus and then monitoring bioﬁlm formation for a total of
3 days as can be seen in panels (B) (KT2) and (C) (RT2). Eradication conditions involved allowing bioﬁlms to grow for 2 days to reach their mature state before addition of either peptide
into the ﬂow-through medium. (A) is a negative control that is a 3-day-old bioﬁlmwithout peptide treatment; (D) and (E) are 0-day-old bioﬁlms treated with KT2 and RT2 respectively.
After 3 days, bacteria attached to the surface of ﬂow cells were stained greenwith the bacteria stain Syto-9 and redwith the dead-bacteria stain propidium iodide (merge shows as yellow
to red) prior to confocal imaging. Each panel shows reconstructions from the top in the large panel and sides in the right and bottom panels (xy, yz and xz dimensions).
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showed less than 50% leakage at the highest peptide to lipid molar
ratio (1:5) (Fig. 5). On the other hand, polymyxin B, RT2 and KT2
were unable to induce leakage of small molecules at all concentrations
tested (Fig. 5). Thus it seemed unlikely that our peptides worked by
busting membranes.
3.6. Interaction with membrane lipids
Since both RT2 and KT2 have tryptophan residues, we could use this
to assess the ability of these peptides to interact with and insert into the
lipid core of LUV since a hydrophobic environment causes an increase in
ﬂuorescence and a blue ﬂuorescence emission maximum at an excita-
tion wavelength of 280 nm. Both peptides interacted with the hydro-
phobic cores of membranes at peptide-to-lipid molar ratios of 1:10 as
can be seen in Table 1, consistentwith the prior observation of increased
α-helicity after interaction with liposomes [22]. KT2 which has greater
hydrophobicity could potentially bury deeper in lipid bilayer than RT2,
due to hydrophobic interactions between peptides and lipid core. The
ability to bury deeper in lipid bilayers however would not imply better
translocation of a peptide [23,24]. Indeed peptides with higherFig. 3. LPS binding activity assessed as the I50 of dansyl-polymyxin displacement from
Escherichia coli 0111:B4 LPS. Each value is averaged from three experiments ± the stan-
dard deviation.hydrophobicity might have weaker penetrating ability since peptides
interact more strongly with the lipid core of the liposome [25]. This re-
sult taken together with the lack of membrane leakage indicates that
thepeptidesmight interactwithmembranes in theprocess of transloca-
tion across the bilayer.
3.7. Translocation into bacterial cells
To enable direct visualization of whether these peptides could pen-
etrate bacterial cells, peptides were labeled with FITC labeling. To con-
trol for any effects of labeling on peptide activity, killing curve assays
were conducted. FITC labeling of these peptides reduced the antibacte-
rial activity of the peptides compared to their non-FITC labeled variants
(Fig. 1A and B). Indeed, FITC-RT2 at 2× MIC of RT2 killed all bacterial
cells only after 60 min, whereas RT2 at its MIC killed all cells within
5 min (Fig. 1A). Similarly, FITC-labeled KT2 at 2× MIC of KT2 killed the
entire E. coli O157:H7 population within 20 min, whereas KT2 at its
MIC eradicated all bacteria within 1 min (Fig. 1B). Moreover, a negative
control with FITC alone at a ﬁnal concentration of 24mMshowedno an-
tibacterial activity in any experiments (Fig. 1A and B). SubsequentFig. 4. Liposome aggregation assays. Liposome aggregationwas assessed by the increase in
A450 after the addition to LUV of designed peptides and control peptides polymyxin B,
magainin II and buforin II.
Fig. 5. Liposome leakage assays. Leakage of probe molecules from liposomes induced by
treatment with KT2 and RT2 compared to control peptides polymyxin B, magainin II and
buforin II.
Fig. 6. Translocation studies using live bacterial cells. Translocation of FITC-labeled RT2
and KT2 into bacterial cells (E. coli O157) was visualized by using confocal microscopy.
Panels (A) and (C) correspond to one-half MIC of RT2 and KT2, respectively. Panels (B)
and (D) correspond to 2 × MIC of RT2 and KT2 respectively. The white line in each
panel is equivalent to 5 μm. At 2 × MIC of both peptides, an image corresponding to the
rigid rod of bacterial cells was found in all stacks of confocal imageswhile an image corre-
sponding to the outline of bacterial cells was found in some stacks at one-half MIC of both
peptides.
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to adjust for this lower antibacterial activity. The labeling of peptides
with ﬂuorescent tags can change their biochemical and biophysical
properties and this decrease the killing ability of peptides as observed
here and previously [26]. The lower activity of our FITC labeled peptides
was likely due to the reduction in thepositive charge due to the covalent
bond formed between the N terminal amine and FITC.
To assess whether the peptides could penetrate into E. coli O157:H7
cells or remained membrane associated, we used confocal microscopy
after interacting peptides with cells. At 0.5× MIC, both FITC-labeled
peptides primarily bound to the bacterial membrane and did not pene-
trate into bacterial cells (Fig. 6A and C). These results correlated with
the kill curve assays, in which neither FITC-RT2 (Fig. 1A) nor FITC-KT2
(Fig. 1B) led to substantial bacterial cell killing at these concentrations.
However, at concentrations corresponding to 2× MIC, both FITC-
labeled peptides penetrated rapidly into bacterial cells without
disrupting them and were observed as ﬁlled green rods in all confocal
sections through the cells (Fig. 6B and D). These results correlated
with killing curves using both these ﬂuorescently-labeled peptides at
2× MIC, which indicated complete cell killing within 60 min (Fig. 1A
and B). CPPs are cationic (often amphipathic) peptides that can cross
the cell membrane via energy-independent and/or energy-dependent
mechanisms [27–31]. Many previous studies report that CPPs in which
Lys is replacedwith Arg canmore efﬁciently crossmembranes, although
these studies were generally performed in eukaryotic cells or model
systems with weak electrical potential gradients [31]. However, in this
study involving bacterial uptake into bacterial cells with substantial
electrical potential gradients, differences in the cell penetrating ability
of RT2 and KT2 were not clear since green rods were observed in all
stacks of cells treated with RT2 and KT2.
3.8. Interaction with GUVs
To study the interaction of peptides KT2 and RT2with anothermem-
brane lipid system, we used giant unilamellar vesicles (GUVs) as an ex-
perimental model to mimic bacterial membranes, and visualized
interactions using confocal microscopy. In the absence of peptide, we
observed hollow rigid circles stained red with the Vybrant Dil dye and
correspond to the membranes of the GUVs (Fig. 7). FITC alone, used as
a negative control at a ﬁnal concentration of 1.3 mM, did not penetrateTable 1
Interaction of peptide tryptophan residues with the hydrophobic core of liposomes. This
was assessed as the blue shift in tryptophan maximum emission wavelengths (nm) of
KT2 and RT2 in LUV composed of zwitterionic (DOPC) and anionic (DOPG) phospholipids.
Peptide Tryptophan blue shift (nm)
1:1 (P/L) 1:5 (P/L) 1:10 (P/L)
KT2 10 nm 4 nm 4 nm
RT2 6 nm 2 nm ND
ND indicates not determined since the ﬂuorescence intensity of peptides in buffer could
not be detected.into the GUVs (Fig. 7). Similarly, for FITC-RT2 and FITC-KT2, there were
no green peptide spots in the GUVs as can be seen in the micrographs
and the ﬂuorescent intensity graphs of Fig. 7, thus indicating that they
likely preferentially buried into the bacterial membrane as opposed to
crossing the bilayer into the interior of GUVs. The intact shapes of
peptide-treated GUVs (Fig. 7) suggested that these peptides did not de-
stroy the bacterial membrane-like GUVs. Moreover, the differential
roles of Arg and Lys in RT2 and KT2 respectively in interactingwith bac-
terial membrane mimics was not clear in this study, since they seemed
to have similar activity in penetrating liposomes. The inability of pep-
tides to penetrate well into the interior of GUVs (Fig. 7) contrasts with
their ability to readily cross the membrane of live bacterial cells
(Fig. 6). This is likely due to the electrical potential gradient across the
cytoplasmic membrane of bacterial cells (around−130 mV providing
a force for the inwards movement of cationic peptides) combined
with the presence of negatively-charged intracellular DNA that might
trap the translocated peptides. The reason for this may be the transloca-
tion ability of them depends on the force of electrostatic interaction of
lipid core-burying peptides and negatively charge components. It
should be pointed out that in making GUVs we used PC, which is
compatible as a surrogate for PE, the major phospholipid in the E. coli
membrane. Although, other studies have shown that PE is usually freely
interchangeablewith PC and other neutral lipids in liposome studies it is
possible that the different shape of PC also interferedwith translocation.
3.9. DNA binding
The experiments described above, indicate that it is unlikely that
membrane targeting is the mechanism of action of peptides RT2 and
KT2. Therefore, these peptides were tested for their ability to bind to in-
tracellular DNA (Fig. 8), since the electrostatic interactions between the
positive charges of the peptides, which are burying in the lipid core
(Table 1), and the negative charge of DNAmight lead the peptides to ac-
cumulate within bacterial cells and also provide a potential mechanism
of action [3]. Magainin II, which has poor DNA-binding ability [8,32],
was used as a negative control (Fig. 8). Indeed, magainin II did not
bind to DNA at any of the ratios tested, in accordance with a previous
study [8]. Both peptides RT2 and KT2 bound avidly to DNA (Fig. 6). Pep-
tide KT2 had the strongest ability to bind to DNA at a 1:1 DNA:peptide
weight ratio, which was substantially higher than that previously re-
ported for buforin II (1:10 DNA: peptide weight ratio) [8]. The DNA re-
tardation of peptide RT2 was visualized at a 1:2 DNA:peptide ratio,
which also represented increased binding compared to buforin II
(Fig. 8). These results are consistent with the conclusion that the anti-
bacterial action of peptides KT2 and RT2 might involve DNA binding.
Moreover, comparing the % helical content of RT2 and KT2 in the
Fig. 7. Translocation studies using giant unilamellar vesicles (GUVs). Translocation of FITC-labeled peptides RT2 and KT2 into GUVs. GUVs, which were composed of bacteria-like lipids,
were visualized by using confocalmicroscopy. The panels in column (A) show themorphologies of GUVswhere the red ﬂuorescence of Vybrant Dil dyewas used to label GUVs. The panels
in column (B) indicated the locations of green FITC-labeled peptides and FITC alone (negative control). The panels in column (C) show themerged images of the corresponding images in
columns (A) and (B). The white line in each panel is equivalent to 10 μm. The ﬂuorescent intensity in the corresponding area (the blue line) is shown at the bottom of each panel.
Fig. 8.DNA binding. Peptide binding to DNA as assessed by banding pattern on a 0.75% agarose/TAE gel at different peptide:plasmidweight ratios. The peptide-to-DNAweight ratios were
0:1, 0.5:1, 1:1, 2:1, 4:1 and 8:1, respectively, from left to right. ‘0’ in the ﬁrst lane indicates the negative control (no peptide addition). (A), (B), (C) and (D) are results formagainin II (neg-
ative control peptide), RT2, KT2, and buforin II (positive control peptide), respectively.
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in the previous studies [10], the helical content of these peptides seems
not important for their antibacterial mechanism, which is the same as
buforin II, while the helical content is a distinct characteristics of mem-
brane active peptides such as magainin II [32].
4. Conclusions
This study indicates that the antibacterial mechanisms of peptides
KT2 and RT2 are similar and likely result in uptake across the outer
and cytoplasmic membrane of bacteria leading to DNA binding. The
positively charged peptides were able to interact strongly with nega-
tively charged bacterial surface LPS, by using both electrostatic as well
as hydrophobic interactions. This would lead to self-promoted uptake
and consequent translocation of the peptides to the cytoplasmic mem-
brane. The peptides were shown to associate with and enter into the
membranes of liposomes with similar characteristics to anionic bacteri-
al membranes using both charge:charge and hydrophobic interactions.
Although the literature often suggests that most peptides work by
perturbing membranes [1–3], it was quite clear here that, although
RT2 and KT2 are able to interact with bacteria-like membranes, they
have an extremely low ability to perturb such membranes and in fact
in intact cells they are largely observed within the cells, indicating that
interactionwith themembrane does not lead per se tomembrane dam-
age. These peptides were designed to have both hydrophobic and posi-
tively designed domains in their sequence, so it is likely that their
hydrophobic facets interact with the anionic lipid head groups (phos-
phatidyl glycerol and cardiolipin) at the surface of the cytoplasmic
membrane of E. coli and insert into the hydrophobic core.
Our previous studies using circular dichroism suggested that in
membrane-mimicking environments (LUV or SDS micelles), the sec-
ondary structure of peptides KT2 and RT2 was more ordered into α-
helices (~30–40% α-helix content), which is lower than that recorded
for magainin II and some other membrane-targeting peptides. It is pos-
sible that the shapes of these peptides upon interaction with bacterial
membranes might be bent and this less ordered structure might favor
translocation across the cytoplasmicmembrane leading toDNAbinding.
The electrostatic interaction between polyanionic DNA and polycationic
peptides enable the peptides to bind to DNA (and likely other nucleic
acids) inside the bacterial cells which is observed as completely-ﬁlled
bacterial cells (Fig. 6). Therefore, we propose that themechanism of an-
tibacterial action of peptides RT2 and KT2 is substantially based on their
ability to bind to negatively-charged components of bacterial mem-
branes (LPS and anionic phospholipids), translocate into bacterial cells
(through peptide interactions with other peptide molecules and mem-
brane phospholipids), and subsequently bind to intracellular polynucle-
otides to inhibit macromolecular synthesis.
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